Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-25-078948
Filing Date
2025-05-29
Accepted
2025-05-29 16:09:16
Documents
5
Period of Report
2025-05-28

Document Format Files

Seq Description Document Type Size
1 PRE 14A 2025_annual_meeting_pre_.htm PRE 14A 1416100
2 GRAPHIC img100757442_0.jpg GRAPHIC 15547
3 GRAPHIC img100757442_1.jpg GRAPHIC 15547
4 GRAPHIC img100757442_2.jpg GRAPHIC 477898
5 GRAPHIC img100757442_3.jpg GRAPHIC 202650
  Complete submission text file 0000950170-25-078948.txt   2397319
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

EIN.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39603 | Film No.: 251003379
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)